1
|
Imaz Aristimuño N, Rodriguez Agirretxe I, San Vicente Blanco R, Rotaeche Del Campo R, Mendicute Del Barrio J. Comparison of Cardiovascular Risk and Events among Spanish Patients with and without Ocular Pseudoexfoliation. J Clin Med 2022; 11:jcm11082153. [PMID: 35456246 PMCID: PMC9024962 DOI: 10.3390/jcm11082153] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2022] [Revised: 03/29/2022] [Accepted: 04/08/2022] [Indexed: 11/16/2022] Open
Abstract
The purpose of this study was to calculate and compare individual cardiovascular risk (CVR) and the development of cardiovascular events and mortality in patients with and without ocular pseudoexfoliation (PEX). A cohort study was carried out to compare two groups of patients who underwent cataract surgery: patients with (n = 99) and without PEX (n = 239). The CVR factors were recorded for all the subjects, and CVR was calculated for each individual using ERICE risk assessment charts. After a six-year follow-up, the cardiovascular events and mortality rates were compared between the two groups. The mean CVR was 36.41% in the PEX group and 33.72% in the non-PEX group (p = 0.13). High blood pressure was detected in significantly more PEX patients (71.4%) than non-PEX patients (58.6%, p = 0.035), yet no differences were found in the other CVR factors. The prevalence of cardiovascular events in the PEX and non-PEX patients was 17.1% and 12.5%, respectively (p = 0.26), with 5% of patients in the PEX group and 5% in the non-PEX group suffering an acute coronary event (p = 0.9). Moreover, 12% of the PEX patients and 7.5% of the non-PEX patients experienced a stroke (p = 0.17), and the six-year mortality rate was 29.3% in the PEX group and 25.9% in the non-PEX group (p = 0.52). PEX was associated with high blood pressure in our cohort of patients, although cardiovascular risk was not shown to be higher in this group. In addition, patients with PEX did not experience more cardiovascular events or have a higher mortality rate than patients without PEX during the period studied.
Collapse
Affiliation(s)
- Nora Imaz Aristimuño
- Department of Ophthalmology, Donostia Universitary Hospital, 20014 Donostia-San Sebastian, Spain; (I.R.A.); (J.M.D.B.)
- Correspondence: ; Tel.: +34-6-9578-1891
| | - Iñaki Rodriguez Agirretxe
- Department of Ophthalmology, Donostia Universitary Hospital, 20014 Donostia-San Sebastian, Spain; (I.R.A.); (J.M.D.B.)
| | | | | | - Javier Mendicute Del Barrio
- Department of Ophthalmology, Donostia Universitary Hospital, 20014 Donostia-San Sebastian, Spain; (I.R.A.); (J.M.D.B.)
| |
Collapse
|
2
|
López-González ÁA, Manzanero Z, González San Miguel HM, Arroyo Bote S, Riutord Sbert P, Rigo Vives MDM, Ramírez Manent JI. Differences in cardiovascular risk levels between cleaning staff and hotel housekeepers. J Occup Health 2022; 64:e12320. [PMID: 35229410 PMCID: PMC8886290 DOI: 10.1002/1348-9585.12320] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2021] [Revised: 01/08/2022] [Accepted: 02/10/2022] [Indexed: 11/17/2022] Open
Abstract
Background and objective Cardiovascular diseases are the leading cause of morbidity and mortality worldwide, with a greater incidence in the most disadvantaged social classes. In this study, we aimed to evaluate the level of cardiovascular risk in cleaning workers. Methods This was a descriptive, cross‐sectional study in 46.632 cleaning workers (40.169 women and 6.463 men). Thirty‐one different scales related to cardiovascular risk were studied (14 assessing overweight and obesity, 5 determining the risk of nonalcoholic fatty liver disease, 5 scales of cardiovascular risk, 4 atherogenic indices, and 3 scales of metabolic syndrome, among others). The results obtained were divided between personnel who perform their cleaning tasks in the hotel and catering industry and those in other sectors. Results The prevalence of obesity and arterial hypertension in cleaning workers was over 20% in both sexes. A similar amount was observed in moderate or high values on the REGICOR (Registre GIroní del COR) scale. More than 15% presented metabolic syndrome according to the NCEP ATPIII (National Cholesterol Education Program‐Adult Treatment Program III) criteria, while over 10% of women and 20% of men had a high risk of nonalcoholic fatty liver disease assessed with the fatty liver index. Conclusion Cardiovascular risk is higher, in both sexes, in the group of cleaning workers who work in companies other than hotels.
Collapse
Affiliation(s)
- Ángel Arturo López-González
- ADEMA University School Palma, Balearic Islands, Spain.,Balearic Islands Health Service, Balearic Islands, Spain
| | - Zoe Manzanero
- PREVIS Occupational Health Service, Palma, Balearic Islands, Spain
| | | | | | | | | | | |
Collapse
|
3
|
Cardiovascular risk factors associated with acute myocardial infarction and stroke in the MADIABETES cohort. Sci Rep 2021; 11:15245. [PMID: 34315938 PMCID: PMC8316319 DOI: 10.1038/s41598-021-94121-8] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2020] [Accepted: 07/05/2021] [Indexed: 11/15/2022] Open
Abstract
We aimed to develop two models to estimate first AMI and stroke/TIA, respectively, in type 2 diabetes mellitus patients, by applying backward elimination to the following variables: age, sex, duration of diabetes, smoking, BMI, and use of antihyperglycemic drugs, statins, and aspirin. As time-varying covariates, we analyzed blood pressure, albuminuria, lipid profile, HbA1c, retinopathy, neuropathy, and atrial fibrillation (only in stroke/TIA model). Both models were stratified by antihypertensive drugs. We evaluated 2980 patients (52.8% women; 67.3 ± 11.2 years) with 24,159 person-years of follow-up. We recorded 114 cases of AMI and 185 cases of stroke/TIA. The factors that were independently associated with first AMI were age (≥ 75 years vs. < 75 years) (p = 0.019), higher HbA1c (> 64 mmol/mol vs. < 53 mmol/mol) (p = 0.003), HDL-cholesterol (0.90–1.81 mmol/L vs. < 0.90 mmol/L) (p = 0.002), and diastolic blood pressure (65–85 mmHg vs. < 65 mmHg) (p < 0.001). The factors that were independently associated with first stroke/TIA were age (≥ 75 years vs. < 60 years) (p < 0.001), atrial fibrillation (first year after the diagnosis vs. more than one year) (p = 0.001), glomerular filtration rate (per each 15 mL/min/1.73 m2 decrease) (p < 0.001), total cholesterol (3.88–6.46 mmol/L vs. < 3.88 mmol/L) (p < 0.001), triglycerides (per each increment of 1.13 mmol/L) (p = 0.031), albuminuria (p < 0.001), neuropathy (p = 0.01), and retinopathy (p = 0.023).
Collapse
|
4
|
Orozco-Beltran D, Gil-Guillen VF, Redon J, Martin-Moreno JM, Pallares-Carratala V, Navarro-Perez J, Valls-Roca F, Sanchis-Domenech C, Fernandez-Gimenez A, Perez-Navarro A, Bertomeu-Martinez V, Bertomeu-Gonzalez V, Cordero A, Pascual de la Torre M, Trillo JL, Carratala-Munuera C, Pita-Fernandez S, Uso R, Durazo-Arvizu R, Cooper R, Sanz G, Castellano JM, Ascaso JF, Carmena R, Tellez-Plaza M. Lipid profile, cardiovascular disease and mortality in a Mediterranean high-risk population: The ESCARVAL-RISK study. PLoS One 2017; 12:e0186196. [PMID: 29045483 PMCID: PMC5646809 DOI: 10.1371/journal.pone.0186196] [Citation(s) in RCA: 56] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2017] [Accepted: 09/27/2017] [Indexed: 12/17/2022] Open
Abstract
INTRODUCTION The potential impact of targeting different components of an adverse lipid profile in populations with multiple cardiovascular risk factors is not completely clear. This study aims to assess the association between different components of the standard lipid profile with all-cause mortality and hospitalization due to cardiovascular events in a high-risk population. METHODS This prospective registry included high risk adults over 30 years old free of cardiovascular disease (2008-2012). Diagnosis of hypertension, dyslipidemia or diabetes mellitus was inclusion criterion. Lipid biomarkers were evaluated. Primary endpoints were all-cause mortality and hospital admission due to coronary heart disease or stroke. We estimated adjusted rate ratios (aRR), absolute risk differences and population attributable risk associated with adverse lipid profiles. RESULTS 51,462 subjects were included with a mean age of 62.6 years (47.6% men). During an average follow-up of 3.2 years, 919 deaths, 1666 hospitalizations for coronary heart disease and 1510 hospitalizations for stroke were recorded. The parameters that showed an increased rate for total mortality, coronary heart disease and stroke hospitalization were, respectively, low HDL-Cholesterol: aRR 1.25, 1.29 and 1.23; high Total/HDL-Cholesterol: aRR 1.22, 1.38 and 1.25; and high Triglycerides/HDL-Cholesterol: aRR 1.21, 1.30, 1.09. The parameters that showed highest population attributable risk (%) were, respectively, low HDL-Cholesterol: 7.70, 11.42, 8.40; high Total/HDL-Cholesterol: 6.55, 12.47, 8.73; and high Triglycerides/HDL-Cholesterol: 8.94, 15.09, 6.92. CONCLUSIONS In a population with cardiovascular risk factors, HDL-cholesterol, Total/HDL-cholesterol and triglycerides/HDL-cholesterol ratios were associated with a higher population attributable risk for cardiovascular disease compared to other common biomarkers.
Collapse
Affiliation(s)
- Domingo Orozco-Beltran
- Catedra de Medicina de Familia, Miguel Hernandez University, San Juan de Alicante, Spain
| | - Vicente F. Gil-Guillen
- Catedra de Medicina de Familia, Miguel Hernandez University, San Juan de Alicante, Spain
| | - Josep Redon
- Department of Internal Medicine, Hospital Clinico de Valencia, Valencia, Spain
- INCLIVA Research Institute, Valencia, Spain
- CIBERObn, ISCIII, Madrid, Spain
| | - Jose M. Martin-Moreno
- Department of Preventive Medicine and Public Health, University of Valencia Medical School. Valencia, Spain
| | - Vicente Pallares-Carratala
- Health Surveillance Department, Mutual Society of Castellon. Department of Medicine. Jaume I University. Castellon, Spain
| | - Jorge Navarro-Perez
- Department of Internal Medicine, Hospital Clinico de Valencia, Valencia, Spain
- INCLIVA Research Institute, Valencia, Spain
- Department of Medicine, University of Valencia, Valencia, Spain
| | | | | | | | | | - Vicente Bertomeu-Martinez
- Department of Cardiology, Hospital Universitario San Juan de Alicante, San Juan de Alicante, Spain
- Department of Clinical Medicine, Miguel Hernández University, San Juan de Alicante, Spain
| | - Vicente Bertomeu-Gonzalez
- Department of Cardiology, Hospital Universitario San Juan de Alicante, San Juan de Alicante, Spain
- Department of Clinical Medicine, Miguel Hernández University, San Juan de Alicante, Spain
| | - Alberto Cordero
- Department of Cardiology, Hospital Universitario San Juan de Alicante, San Juan de Alicante, Spain
- Department of Clinical Medicine, Miguel Hernández University, San Juan de Alicante, Spain
| | | | - Jose L. Trillo
- Department of Pharmacy, Hospital Clinico de Valencia, Valencia, Spain
| | | | - Salvador Pita-Fernandez
- Clinical Epidemiology and Biostatistics Unit, Complexo Hospitalario Universitario A Coruña (CHUAC), SERGAS, Universidad de A Coruña, A Coruña, Spain
| | - Ruth Uso
- Pharmacy Management. Conselleria de Sanitat. Valencia, Spain
| | - Ramon Durazo-Arvizu
- Department of Public Health Sciences, Stritch School of Medicine, Loyola University Chicago, Maywood, IL, United States of America
| | - Richard Cooper
- Department of Public Health Sciences, Stritch School of Medicine, Loyola University Chicago, Maywood, IL, United States of America
| | - Gines Sanz
- National Cardiovascular Research Center. Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain
| | - Jose M. Castellano
- National Cardiovascular Research Center. Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain
- HM Hospitales, Hospital Universitario HM Monteprincipe, Madrid, Spain
| | - Juan F. Ascaso
- Service of Endocrinology and Nutrition, Hospital Clínico de Valencia. University of Valencia, Valencia, Spain
- INCLIVA Research Institute. Ciber de Diabetes y Enfermedades Metabólicas (CIBERDEM), Carlos III. Valencia, Spain
| | - Rafael Carmena
- Service of Endocrinology and Nutrition, Hospital Clínico de Valencia. University of Valencia, Valencia, Spain
- INCLIVA Research Institute. Ciber de Diabetes y Enfermedades Metabólicas (CIBERDEM), Carlos III. Valencia, Spain
| | - Maria Tellez-Plaza
- Institute for Biomedical Research. Hospital Clinic de Valencia, Valencia, Spain
- Department of Environmental Health Sciences, Johns Hopkins University Bloomberg School of Public Health, Baltimore, United States of America
| | | |
Collapse
|